UK call for clarity after EU ruling on gene-edited crops
−− An open letter, signed by leading research institutions, universities, plant breeders, crop agronomy companies and biotech multinationals, is delivered to Defra Secretary
Sep. 14, 2018
|The letter has been signed by 33 UK organisations
An open letter, signed by leading research institutions, universities, plant breeders, crop agronomy companies and biotech multinationals, was delivered to Defra Secretary of State Michael Gove on Thursday (13 September).
The group of 33 signatories, which also includes farmer and landowner organisations, collectively undertakes hundreds of millions of pounds of private and public-funded research and development into plant science every year, employing hundreds of scientists and crop specialists across the UK.
The letter requests a round-table meeting involving all stakeholders and Defra to agree a clear way forward on research and future use of new plant-breeding technologies.
It adds: “We feel there are significant questions that must be addressed urgently by government if the UK is to retain its strength in plant genetics, to use innovation to boost productivity and competitiveness, and to meet the challenges of nutritional health and environmental protection.”
The move follows the shock ruling in July by the Court of Justice of the European Union (CJEU) that concluded organisms obtained by newer forms of mutagenesis, such as gene-editing, are GMOs.
Unlike traditional genetic modification which may involve insertion of foreign DNA into an organism, gene-editing is a group of technologies involving the precise replacement of one DNA sequence with another.
This ruling went against the recommendation to exempt new techniques, made by the EU Advocate General in January. It also differs from the position taken by other global authorities, such as those in the US and China, that they should be treated as bred by conventional techniques.
Defra has since reiterated its view that “gene-edited organisms should not be regulated as GMOs if the changes to their DNA could have occurred naturally or through traditional breeding methods”.
The views expressed in the letter were drawn together by Oxfordshire farmer and editor of Crop Production Magazine Tom Allen-Stevens, working with the National Farmers’ Union.
“As a farmer myself, I’m greatly concerned that as a result of this ruling, the fruits of this valuable research may never reach my farm, and that research into gene-edited crops in the UK may cease altogether,” he said.
The CJEU ruling in July drew widespread concern from many research organisations at the cutting edge of plant science.
Professor Wendy Harwood, of the department of Crop Genetics at the John Innes Centre said: “The CJEU decision could have major negative impacts on our ability to respond rapidly to the challenges of providing sufficient, nutritious food, under increasingly challenging conditions.”
Professor Nick Talbot, director of The Sainsbury Laboratory, Norwich, described the ruling as: “a retrograde step that is not based on any scientific evidence,” adding. “Precise modern gene editing technologies allow accurate, predictable changes to be made in a genome. To classify gene edited crops as GMOs and equivalent to transgenic crops is completely incorrect by any scientific definition.”
The 33 signatories of the letter are:
- John Innes Centre
- Rothamsted Research
- James Hutton Institute
- Aberystwyth University
- The Sainsbury Laboratory (Norwich)
- Quadram Institute
- Earlham Institute
- Professor Denis Murphy
- Professor Ian Crute
- National Farmers Union
- Tenant Farmers Association
- Country Land & Business Association
- Linking Environment And Farming
- RASE and Innovation for Agriculture
- British Society of Plant Breeders
- Limagrain UK
- RAGT UK
- KWS UK
- Elsoms Seeds
- HL Hutchinson
- Frontier Agriculture
- Syngenta UK
- BASF Agricultural Solutions
- Corteva Agriscience
- Agricultural Biotechnology Council
- Agricultural Industries Confederation
More from AgroNews
- Top 20 Brazilian agrochem companies in 2017: Mergers will increase market concentration in the future
- Sichuan Lomon Bio Takes S-ABA and Gibberellin as Core Products to Build Full Range Product Line on Basis of Biotechnology
- AkzoNobel Specialty Chemicals rebrands as Nouryon
- What venture capital looks for in agricultural start-ups